CWE-16204-58198 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Registered in v-safe
2021-03-13
Dose 1 — Janssen/Johnson & Johnson
2021-03-13
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Redness · Headache, Fatigue or tiredness

Adult check-in
2021-03-18
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Redness, Itching · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-03-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-20
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-27
Survey response — day 14, dose 1
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Severe headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-03
Health check-in — day 21, single dose
Feeling: Fair

Adult check-in
2021-04-10
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-04-26
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-06-14
Health check-in — 3 months, dose 1
Feeling: Fair

Adult check-in
2022-03-14
Survey response — 12 months, dose 1
MedDRA: Laboratory test abnormal — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Suffered from testing positive in January 2022

MedDRA releases: 2024-11 · check-in free text available
2022-03-14
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-17
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Janssen/Johnson & Johnson

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 6 — day 14, dose 1

2021-03-27

Symptoms: Severe headache

Release 11 — 12 months, dose 1

2022-03-14

Symptoms: Suffered from testing positive in January 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	✓	✓	✓
SD	Laboratory test abnormal	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release